Literature DB >> 18809838

Familiality in brain tumors.

Deborah T Blumenthal1, Lisa A Cannon-Albright.   

Abstract

BACKGROUND: Familiality in brain tumors is not definitively substantiated.
METHODS: We used the Utah Population Data Base (UPDB), a genealogy representing the Utah pioneers and their descendants, record-linked to statewide cancer records, to describe the familial nature of primary brain cancer. We examined the familial clustering of primary brain tumors, including subgroups defined by histologic type and age at diagnosis. The UPDB includes 1,401 primary brain tumor cases defined as astrocytoma or glioblastoma, all with at least three generations of genealogy data. We tested the hypothesis of excess relatedness of brain tumor cases using the Genealogical Index of Familiality method. We estimated relative risks for brain tumors in relatives using rates of brain tumors estimated internally.
RESULTS: Significant excess relatedness was observed for astrocytomas and glioblastomas considered as a group (n = 1,401), for astrocytomas considered separately (n = 744), but not for glioblastomas considered separately (n = 658). Significantly increased risks to first- and second-degree relatives for astrocytomas were identified for relatives of astrocytomas considered separately. Significantly increased risks to first-degree relatives, but not second degree, were observed for astrocytoma and glioblastoma cases considered together, and for glioblastoma cases considered separately.
CONCLUSIONS: This study provides strong evidence for a familial contribution to primary brain cancer risk. There is evidence that this familial aspect includes not only shared environment, but also a heritable component. Extended high-risk brain tumor pedigrees identified in the UPDB may provide the opportunity to identify predisposition genes responsible for familial brain tumors.

Entities:  

Mesh:

Year:  2008        PMID: 18809838      PMCID: PMC2676956          DOI: 10.1212/01.wnl.0000326597.60605.27

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Association of adult glioma with medical conditions, family and reproductive history.

Authors:  F M Cicuttini; S F Hurley; A Forbes; G A Donnan; M Salzberg; G G Giles; J J McNeil
Journal:  Int J Cancer       Date:  1997-04-10       Impact factor: 7.396

2.  Genetics in intracranial tumours.

Authors:  M HAUGE; B HARVALD
Journal:  Acta Genet Stat Med       Date:  1957

3.  Mormon demographic history I. Nuptiality and fertility of once-married couples.

Authors:  M Skolnick; L Bean; D May; V Arbon; K De Nevers; P Cartwright
Journal:  Popul Stud (Camb)       Date:  1978-03

4.  Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study.

Authors:  B Malmer; H Grönberg; A T Bergenheim; P Lenner; R Henriksson
Journal:  Int J Cancer       Date:  1999-05-05       Impact factor: 7.396

Review 5.  Brain tumor-polyposis syndrome: two genetic diseases?

Authors:  F Paraf; S Jothy; E G Van Meir
Journal:  J Clin Oncol       Date:  1997-07       Impact factor: 44.544

6.  Evidence for a heritable component in death resulting from aortic and mitral valve diseases.

Authors:  Benjamin D Horne; Nicola J Camp; Joseph B Muhlestein; Lisa A Cannon-Albright
Journal:  Circulation       Date:  2004-11-01       Impact factor: 29.690

7.  Central nervous system cancers in first-degree relatives and spouses.

Authors:  S A Grossman; M Osman; R Hruban; S Piantadosi
Journal:  Cancer Invest       Date:  1999       Impact factor: 2.176

8.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

9.  The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.

Authors:  S V Tavtigian; J Simard; J Rommens; F Couch; D Shattuck-Eidens; S Neuhausen; S Merajver; S Thorlacius; K Offit; D Stoppa-Lyonnet; C Belanger; R Bell; S Berry; R Bogden; Q Chen; T Davis; M Dumont; C Frye; T Hattier; S Jammulapati; T Janecki; P Jiang; R Kehrer; J F Leblanc; J T Mitchell; J McArthur-Morrison; K Nguyen; Y Peng; C Samson; M Schroeder; S C Snyder; L Steele; M Stringfellow; C Stroup; B Swedlund; J Swense; D Teng; A Thomas; T Tran; M Tranchant; J Weaver-Feldhaus; A K Wong; H Shizuya; J E Eyfjord; L Cannon-Albright; M Tranchant; F Labrie; M H Skolnick; B Weber; A Kamb; D E Goldgar
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

10.  Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.

Authors:  A Kamb; D Shattuck-Eidens; R Eeles; Q Liu; N A Gruis; W Ding; C Hussey; T Tran; Y Miki; J Weaver-Feldhaus
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

View more
  23 in total

1.  Searching for the roots of brain cancer.

Authors:  Neil Savage
Journal:  Nature       Date:  2018-09       Impact factor: 49.962

2.  Childhood central nervous system tumors and leukemia: Incidence and familial risk. A comparative population-based study in Utah and Norway.

Authors:  Ruby Del Risco Kollerud; Lisa A Cannon-Albright; Hege S Haugnes; Ellen Ruud; Magne Thoresen; Per Nafstad; Karl Gerhard Blaasaas; Øyvind Naess; Bjørgulf Claussen
Journal:  Pediatr Blood Cancer       Date:  2020-05-21       Impact factor: 3.167

Review 3.  Inherited predisposition to glioma.

Authors:  Athanassios P Kyritsis; Melissa L Bondy; Jasti S Rao; Chrissa Sioka
Journal:  Neuro Oncol       Date:  2009-11-23       Impact factor: 12.300

4.  A Comparative Study of the Molecular Characteristics of Familial Gliomas and Other Cancers.

Authors:  Jie Lu; Mark G Burnett; Max Shpak
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

5.  Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.

Authors:  Philip Jonsson; Andrew L Lin; Robert J Young; Natalie M DiStefano; David M Hyman; Bob T Li; Michael F Berger; Ahmet Zehir; Marc Ladanyi; David B Solit; Angela G Arnold; Zsofia K Stadler; Diana Mandelker; Michael E Goldberg; Juliann Chmielecki; Maryam Pourmaleki; Shahiba Q Ogilvie; Shweta S Chavan; Andrew T McKeown; Malbora Manne; Allison Hyde; Kathryn Beal; T Jonathan Yang; Craig P Nolan; Elena Pentsova; Antonio Omuro; Igor T Gavrilovic; Thomas J Kaley; Eli L Diamond; Jacqueline B Stone; Christian Grommes; Adrienne Boire; Mariza Daras; Anna F Piotrowski; Alexandra M Miller; Philip H Gutin; Timothy A Chan; Viviane S Tabar; Cameron W Brennan; Marc Rosenblum; Lisa M DeAngelis; Ingo K Mellinghoff; Barry S Taylor
Journal:  Clin Cancer Res       Date:  2019-07-01       Impact factor: 12.531

6.  Familial risks in nervous system tumours: joint Nordic study.

Authors:  K Hemminki; S Tretli; J H Olsen; L Tryggvadottir; E Pukkala; J Sundquist; C Granström
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

7.  Discriminating risk and resilience endophenotypes from lifetime illness effects in familial major depressive disorder.

Authors:  Bradley S Peterson; Zhishun Wang; Guillermo Horga; Virginia Warner; Bret Rutherford; Kristin W Klahr; Barbara Graniello; Priya Wickramaratne; Felix Garcia; Shan Yu; Xuejun Hao; Phillip B Adams; Ming Qian; Jun Liu; Andrew Gerber; Myrna M Weissman
Journal:  JAMA Psychiatry       Date:  2014-02       Impact factor: 21.596

8.  Increased Default Mode Network Connectivity in Individuals at High Familial Risk for Depression.

Authors:  Jonathan Posner; Jiook Cha; Zhishun Wang; Ardesheer Talati; Virginia Warner; Andrew Gerber; Bradley S Peterson; Myrna Weissman
Journal:  Neuropsychopharmacology       Date:  2015-11-23       Impact factor: 7.853

9.  Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.

Authors:  Daniel I Jacobs; Kazutaka Fukumura; Matthew N Bainbridge; Georgina N Armstrong; Spiridon Tsavachidis; Xiangjun Gu; Harsha V Doddapaneni; Jianhong Hu; Joy C Jayaseelan; Donna M Muzny; Jason T Huse; Melissa L Bondy
Journal:  Neuro Oncol       Date:  2018-11-12       Impact factor: 12.300

10.  Genome-wide analysis of high-risk primary brain cancer pedigrees identifies PDXDC1 as a candidate brain cancer predisposition gene.

Authors:  Lisa A Cannon-Albright; James M Farnham; Jeffrey Stevens; Craig C Teerlink; Cheryl A Palmer; Kerry Rowe; Melissa H Cessna; Deborah T Blumenthal
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.